Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
- Terminas
- 2027-09-16
- Atidaryta
- 2027-02-10
- Biudžetas
- 115 323 812 €
- Tipas
- grant
Aprašymas
Expected Outcome:This action supports the follow-up to the July 2023 Communication on EU Missions assessment[1]. Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes:Public procurers, possibly in cooperation with private ones, in the area of cancer-centred healthcare stimulate the competitive development of market-ready, affordable, innovative solutions.The chosen solutions take into consideration the needs of cancer patients living with and beyond cancer through research that supports end-user engagement using participative research models.Procurers create opportunities for European health, technology and medical devices, industrial actors (including start-ups, spin-offs, spin-outs, scale-ups, SMEs) to bring to the market affordable innovations that are cost-efficient, safe and have demonstrated improved health outcomes for cancer patients living with and beyond cancer.Procurers facilitate the commercialisation of innovative solutions for and with cancer patients by their successful suppliers through providing them with first customer references for the validation and first pilot deployment.Policymakers, healthcare providers and professionals, cancer patients and their carers – each in their respective areas – exchange and adopt good practices and the best treatment, technology and medical device solutions that the market can deliver through participative research. Scope:Pre-
Tinkamumas (iš šaltinio)
General conditions1. Admissibility conditions: Proposal page limit and layoutdescribed in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.2. Eligible countriesdescribed in Annex B of the Work Programme General Annexes.A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.3. Other Eligibility ConditionsThe specific conditions for actions with PCP/PPI procurements in section H of the General Annexes apply to grants funded under this topic.described in Annex B of the Work Programme General Annexes.4. Financial and operational capacity and exclusiondescribed in Annex C of the Work Programme General Annexes.5a. Evaluation and award: Award criteria, scoring and thresholdsdescribed in Annex D of the Work Programme General Annexes.5b. Evaluation and award: Submission and evaluation processesdescribed in Annex F of the Work Programme General Annexes and the Online Manual.5c. Evaluation and award: Indicative timeline for evaluation and grant agreementdescribed in Annex F of the Work Programme General Annexes.6. Legal and financial set-up of the grantsThe specific conditions are described in General Annex H.PCP procurement costs are eligible.The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5.described in Annex G of the Work Programme General Annexes.Specific conditions described in the specific topic of the Work Programme Application and evaluation forms and model grant agreement (MGA): Application form templatesPlease use the application form that you will find in the Submission System. You can find examples of standard application forms in the Reference Documents page.Evaluation form templates — will be used with the necessary adaptationsStandard evaluation form (HE PCP PPI) GuidanceHE Programme Guide Model Grant Agreements (MGA)HE MGA Call-specific instructions Information on financial support to third parties (HE) Additional documents: HE Main Work Programme 2026-2027 – 1. General IntroductionHE Main Work Programme 2026-2027 – 12. MissionsHE Main Work Programme 2026-2027 – 15. General AnnexesHE Framework Programme and Rules for Participation Regulation 2021/695HE Specific Programme Decision 2021/764EU Financial Regulation 2024/2509Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity AssessmentEU Grants AGA — Annotated Model Grant AgreementFunding & Tenders Portal Online ManualFunding & Tenders Portal Terms and Conditions Funding & Tenders Portal Privacy Statement
Ar šis kvietimas tinka jūsų organizacijai?
Nariams — automatinis tinkamumo vertinimas pagal jūsų profilį, raktažodžių paieška, filtrai, stebėjimo sąrašas ir pranešimai apie naujus panašius kvietimus.